As of 2025-07-07, the Relative Valuation of Apyx Medical Corp (APYX) is (19.62) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.29 USD, the upside of Apyx Medical Corp based on Relative Valuation is -956.7%.
The range of the Relative Valuation is (19.32) - (19.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 36.4x - 44.9x | 39.2x |
| Forward P/E multiples | 34.1x - 37.7x | 34.8x |
| Fair Price | (19.32) - (19.97) | (19.62) |
| Upside | -943.7% - -972.0% | -956.7% |
| Date | P/E |
| 2025-07-03 | -4.32 |
| 2025-07-02 | -4.05 |
| 2025-07-01 | -4.22 |
| 2025-06-30 | -4.24 |
| 2025-06-27 | -4.07 |
| 2025-06-26 | -4.22 |
| 2025-06-25 | -3.58 |
| 2025-06-24 | -4.28 |
| 2025-06-23 | -3.77 |
| 2025-06-20 | -3.77 |
| 2025-06-18 | -3.23 |
| 2025-06-17 | -3.32 |
| 2025-06-16 | -3.51 |
| 2025-06-13 | -3.30 |
| 2025-06-12 | -3.23 |
| 2025-06-11 | -3.32 |
| 2025-06-10 | -3.43 |
| 2025-06-09 | -3.26 |
| 2025-06-06 | -3.15 |
| 2025-06-05 | -3.13 |
| 2025-06-04 | -3.13 |
| 2025-06-03 | -3.06 |
| 2025-06-02 | -3.06 |
| 2025-05-30 | -2.94 |
| 2025-05-29 | -3.02 |
| 2025-05-28 | -3.15 |
| 2025-05-27 | -3.32 |
| 2025-05-23 | -2.90 |
| 2025-05-22 | -3.13 |
| 2025-05-21 | -2.79 |
| 2025-05-20 | -2.81 |
| 2025-05-19 | -2.81 |
| 2025-05-16 | -2.70 |
| 2025-05-15 | -2.79 |
| 2025-05-14 | -2.66 |
| 2025-05-13 | -2.98 |
| 2025-05-12 | -2.08 |
| 2025-05-09 | -2.19 |
| 2025-05-08 | -2.23 |
| 2025-05-07 | -2.36 |
| 2025-05-06 | -2.02 |
| 2025-05-05 | -2.19 |
| 2025-05-02 | -2.36 |
| 2025-05-01 | -2.02 |
| 2025-04-30 | -1.96 |
| 2025-04-29 | -1.77 |
| 2025-04-28 | -1.70 |
| 2025-04-25 | -1.68 |
| 2025-04-24 | -1.72 |
| 2025-04-23 | -1.70 |